527 related articles for article (PubMed ID: 17565561)
1. Methamphetamine and cardiovascular pathology: a review of the evidence.
Kaye S; McKetin R; Duflou J; Darke S
Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
[TBL] [Abstract][Full Text] [Related]
2. A review of the clinical pharmacology of methamphetamine.
Cruickshank CC; Dyer KR
Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
[TBL] [Abstract][Full Text] [Related]
3. [Driving under the influence of amphetamine and metamphetamine].
Lia K; Spigset O; Slørdal L
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
[TBL] [Abstract][Full Text] [Related]
4. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
5. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
Griffiths P; Mravcik V; Lopez D; Klempova D
Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic abnormalities in methamphetamine abusers.
Haning W; Goebert D
Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
[TBL] [Abstract][Full Text] [Related]
7. Major physical and psychological harms of methamphetamine use.
Darke S; Kaye S; McKetin R; Duflou J
Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of methamphetamine use and harm in Australia.
Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine and its impact on dental care.
Klasser GD; Epstein J
J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
[TBL] [Abstract][Full Text] [Related]
10. The methamphetamine epidemic and dentistry.
Klasser GD; Epstein JB
Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
[TBL] [Abstract][Full Text] [Related]
11. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
Kay-Lambkin FJ
Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine and meth mouth: an overview.
Williams N; Covington JS
J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
[No Abstract] [Full Text] [Related]
13. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
Degenhardt L; Baker A; Maher L
Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
[No Abstract] [Full Text] [Related]
15. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
Maxwell JC; Rutkowski BA
Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
[TBL] [Abstract][Full Text] [Related]
16. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users.
Kim DJ; Roh S; Kim Y; Yoon SJ; Lee HK; Han CS; Kim YK
Neurosci Lett; 2005 Nov; 388(2):112-5. PubMed ID: 16039058
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects and management of methamphetamine abuse.
Romanelli F; Smith KM
Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
Volz TJ; Fleckenstein AE; Hanson GR
Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine abuse and dentistry.
Hamamoto DT; Rhodus NL
Oral Dis; 2009 Jan; 15(1):27-37. PubMed ID: 18992021
[TBL] [Abstract][Full Text] [Related]
20. Why do we need an Addiction supplement focused on methamphetamine?
Rawson RA; Condon TP
Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
